Your browser doesn't support javascript.
loading
Lymphatic versus Hematogenous Melanoma Metastases: Support for Biological Heterogeneity without Clear Clinical Application.
Kasumova, Gyulnara G; Haynes, Alex B; Boland, Genevieve M.
Afiliação
  • Kasumova GG; Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Haynes AB; Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Boland GM; Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA. Electronic address: gmboland@partners.org.
J Invest Dermatol ; 137(12): 2466-2468, 2017 12.
Article em En | MEDLINE | ID: mdl-29169461
ABSTRACT
Melanoma demonstrates considerable biological heterogeneity and is associated with several routes of dissemination including lymphatic and hematogenous. Locoregional control via surgery may improve outcomes for patients with limited lymphatic metastases. Once stage IV disease is diagnosed, clinical outcomes are determined by molecular and/or immunologic factors and identification of tumor/microenvironmental features correlating with distant metastases is critical for future prognostic stratification.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article